Last updated 2026-08-06
- Raised $2.1M Pre-Seed round led by NGT HealthCare II, Feb 2026
Total raised
$2.1M
Stage
—
Founded
2026
Headcount
—
HQ
Nazareth, Israel
Sector
Health Tech & Life Sciences
About
Kailo Pharma is an Israeli medical startup commercializing University of Haifa research aimed at directly treating PTSD. Its lead approach targets a newly identified brain mechanism tied to pathological amplification of traumatic memories, with the goal of weakening trauma intensity without erasing normal memory. The company is developing a peptide-based therapy intended for nasal delivery to reach the central nervous system.
Funding history · 1 round · $2.1M total
2026-02
Pre-Seed
$2.1M
★ NGT HealthCare IIIsrael Innovation Authority
Q&A
- What is Kailo Pharma's primary focus?
- Kailo Pharma is an Israeli medical startup developing a peptide-based nasal spray to treat post-traumatic stress disorder (PTSD) by weakening traumatic memories without affecting normal recall.
- When was Kailo Pharma founded?
- Kailo Pharma was founded in 2026.
- What is Kailo Pharma's total funding to date?
- Kailo Pharma has raised a total of $2,100,000 USD.
- Which investors participated in Kailo Pharma's Pre-Seed round?
- Kailo Pharma's Pre-Seed round in March 2026 included investments from NGT HealthCare II.
- Who are the scientific founders of Kailo Pharma?
- The scientific founders of Kailo Pharma are Dr. Iris Reuveni and Prof. Edi Barkai, both appointed in February 2026.
- Who is the CEO of Kailo Pharma?
- Dr. Osnat On is the CEO of Kailo Pharma, appointed in 2026.
- What is Kailo Pharma's relationship with the University of Haifa?
- Kailo Pharma commercializes research from the University of Haifa, and Carmel, the university's technology transfer company, owns Kailo Pharma.
- What is the employee count for Kailo Pharma?
- As of August 2026, Kailo Pharma has 5 employees.
Team · 3
Dr. Iris Reuveni
Founder · Scientific Founder / Research Lead
Prof. Edi Barkai
Founder · Scientific Founder / Research Lead
Dr. Osnat On
CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Kailo Pharma |
|---|---|
| Founded | 2026 |
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517304689 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2026-02-23 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), shares_capital (1) |
| Registered address | ואדי אל-חאג' 16 נצרת |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-04 | עדכון דירקטורים-הוספת דירקטור |
| 2026-06-01 | הקצאת מניות |